WT1 and neoplasm: The Wilms' tumor 1 (WT1)‐pulsed DC vaccination therapy derived stable disease in 50% of the patients treated with WT1‐pulsed DC vaccination, with neurological improvements and tumor shrinkage observed in 20% of these patients.108